News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Stenhouse Mark
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Stenhouse Mark (COO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 12,754 shares
@ $0
Disposed/sold 14,000 shares
@ $0
Disposed/sold 40,000 options to buy
@ $0.5, valued at
$20k
Disposed/sold 240,000 options to buy
@ $6.7, valued at
$1.6M
Disposed/sold 70,371 options to buy
@ $36.32, valued at
$2.6M
Disposed/sold 86,582 options to buy
@ $29.56, valued at
$2.6M
Disposed/sold 34,085 options to buy
@ $110.2, valued at
$3.8M
|
|
| 06/02/2023 |
4
| Stenhouse Mark (COO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed of 14,000 shares
@ $0
Acquired 14,000 shares
@ $0 |
|
| 05/30/2023 |
4
| Stenhouse Mark (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 12/13/2022 |
4
| Stenhouse Mark (COO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 9,811 shares
@ $0
Granted 34,085 options to buy
@ $110.2, valued at
$3.8M
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Stenhouse Mark (COO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 86,582 options to buy
@ $29.56, valued at
$2.6M
|
|
| 11/16/2021 |
4
| Stenhouse Mark (COO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 70,371 options to buy
@ $36.32, valued at
$2.6M
|
|
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Stenhouse Mark (COO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Bought 14,000 shares
@ $19, valued at
$266k
|
|
| 03/11/2021 |
3
| Stenhouse Mark (COO) has filed a Form 3 on Prometheus Biosciences, Inc. |
| 04/06/2020 |
4
| Stenhouse Mark (President, Cologuard) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Sold 11,948 shares
@ $56.69, valued at
$677.3k
Exercised 25,000 restricted stock units
@ $0 |
|
| 03/19/2020 |
4
| Stenhouse Mark (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $29.84, valued at
$596.8k
|
|
| 03/19/2020 |
3
| Stenhouse Mark (Director) has filed a Form 3 on Phathom Pharmaceuticals, Inc. |
| 02/28/2020 |
4
| Stenhouse Mark (President, Cologuard) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Sold 1,051 shares
@ $80.27, valued at
$84.4k
Exercised 3,262 restricted stock units
@ $0 |
|
| 02/18/2020 |
4
| Stenhouse Mark (President, Cologuard) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 14,123 restricted stock units
@ $0
Granted 11,445 options to buy
@ $98.18, valued at
$1.1M
|
|
| 04/04/2019 |
4
| Stenhouse Mark (President, Cologuard) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Sold 11,192 shares
@ $92.539, valued at
$1M
Exercised 25,000 restricted stock units
@ $0 |
|
| 02/28/2019 |
4
| Stenhouse Mark (President, Cologuard) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 10,786 options to buy
@ $92.62, valued at
$999k
Granted 13,051 restricted stock units
@ $0 |
|
| 04/03/2018 |
4
| Stenhouse Mark (President, Cologuard) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 75,000 restricted stock units
@ $0 |
|
| 04/03/2018 |
3
| Stenhouse Mark (President, Cologuard) has filed a Form 3 on EXACT SCIENCES CORP |
|
|